United States Hyperglycemics Research
11 comprehensive market analysis studies and research reports on the United States Hyperglycemics sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 79 companies, enriched with industry statistics, insights, and a lot more.
TRENDING REPORTS
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market
CAGR: 4.27%
Study Period: 2020 - 2031
Middle East And Africa Insulin Market
CAGR: 3.73%
Study Period: 2020 - 2031
Middle East And Africa Meglitinide Market
CAGR: 4%
Study Period: 2019 - 2030
APAC Meglitinide Market
CAGR: 1.7%
Study Period: 2019 - 2030
Europe Meglitinide Market
CAGR: 2.30%
Study Period: 2019 - 2030
Healthcare
Categories
11 Healthcare Reports
Categories
Showing 11 of 11 results in Hyperglycemics
Insulin Market
CAGR: 3.62%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: United States
Major Players:Novo Nordisk, Eli Lilly and Company, Pfizer, Sanofi, Biocon Biologics Ltd.
Starting at:$4,750
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Market
CAGR: 8.05%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: United States
Major Players:Janssen, Boehringer Ingelheim, Eli Lilly and Company, Astellas Pharma, AstraZeneca
Starting at:$4,750
North America Meglitinide Market
CAGR: 1.5%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: United States
Major Players:Novo Nordisk, Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon
Starting at:$4,750
North America Sulfonylureas Market
CAGR: 1.9%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: United States
Major Players:Mylan, Lupin, Merck, Pfizer, Sanofi
Starting at:$4,750
Insulin Glargine Market
CAGR: 6.05%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: United States
Major Players:Sanofi, Novo Nordisk, Biocon, Eli Lilly and Company, Julphar
Starting at:$4,750
Sulfonylureas Market
CAGR: 3.12%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: United States
Major Players:Sanofi, Pfizer, Merck, Torrent Pharmaceuticals, Dr. Reddy’s Laboratories
Starting at:$4,750
North America Biguanide Market
CAGR: 2.59%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: United States
Major Players:Sanofi, Bristol-Myers Squibb, Glenmark Pharmaceuticals, Takeda Pharmaceuticals, Merck
Starting at:$4,750
Meglitinide Market
CAGR: 2.21%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: United States
Major Players:Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon, Novo Nordisk
Starting at:$4,750
Biguanides Market
CAGR: 2.22%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: United States
Major Players:Bristol-Myers Squibb, Glenmark Pharmaceuticals, Takeda Pharmaceuticals, Sanofi, Merck
Starting at:$4,750
North America Sodium-Dependent Glucose Co-Transporter 2 (SGLT2) Market
CAGR: 7.68%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: United States
Major Players:Janssen, Eli Lilly and Company, AstraZeneca, Boehringer Ingelheim, Astellas Pharma
Starting at:$4,750
North America Insulin Market
CAGR: 3.91%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: United States
Major Players:Sanofi, Novo Nordisk, Eli Lilly and Company, Pfizer, Biocon
Starting at:$4,750
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
